600479 · CN

千金药业 (600479) Lock-Up & Share Unlock Dates

Restricted-share unlock

Follow stock
Lock-up expiration / release datein 1 dayMarket date context: Asia/Shanghai. Check the source for the exact release time.
Expected date · Source verified
Shares subject to release
19.96M shares
% of total shares
4.055%

Original Disclosure & Evidence

Verified

Expected date stated in the source; subject to subsequent disclosures.

Read original disclosure

Evidence reading notes

The passages below are located within the saved evidence summary by date, share or restriction terms. Summaries are not verbatim quotations or independent verification. Refer to the original document for complete terms.

Dates in the evidence
巨潮2026-10-17限售股公告PDF第1页:发行人株洲千金药业股份有限公司,证券简称千金药业、代码600479;本次解除限售/上市流通日期2026-10-23,数量19,958,905股。
Read the full saved evidence summary
巨潮2026-10-17限售股公告PDF第1页:发行人株洲千金药业股份有限公司,证券简称千金药业、代码600479;本次解除限售/上市流通日期2026-10-23,数量19,958,905股。第4页本批占总股本4.055%,分母为总股本,未据此填写流通股本比例。发行股份及支付现金购买资产暨关联交易的部分限售股;本次表列20名股东,使用本批解除限售合计,不使用全部重组发行量。交易所上海证券交易所(SSE)见本公告第3页。以上为已披露的计划流通安排,保持expected;未另行区分实际可出售股数,actual_shares_unlocked为空,未以名义解禁量替代。
Evidence verified
Oct 20, 2026, 10:42 AM
Updated at
Oct 20, 2026, 10:42 AM

What this record establishes

This records a disclosed restriction or sale-eligibility window. Date verification and share-count verification are separate. Reaching the date does not prove a sale occurred or that your account is cleared to trade.

Date status: expected, as stated in the source. A past date is not automatic evidence of completion.

Additional items to verify

  • Free-float impact is not verified. A ratio needs a dated, compatible free-float denominator.
  • Exact release time and time zone, covered holders, early-release conditions and broker processing must be checked in the applicable documents.